Abe I, Saito S, Hori K, Suzuki M, Sato H
Eur J Cancer Clin Oncol. 1983 Jul;19(7):941-4. doi: 10.1016/0277-5379(83)90062-7.
Parameters for metabolism of 1-beta-D-arabinofuranosylcytosine (ara-C) were examined to know whether the prediction of ara-C sensitivity is possible or not using 9 human lymphoblastic cell lines, 3 T cell lines and 6 B cell lines in vitro. Neither the capacity for synthesis, degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate (ara-CTP), generally lower in the T than B cell lines, nor deamination of ara-C, negligible in the B cell lines, could be correlated to the drug sensitivity. On the other hand, significant correlation was obtained between the sensitivity and the plateau level of ara-CTP. We consider that ara-C sensitivity could be predicted by measuring the plateau ara-CTP level before commencement of chemotherapy.
检测了1-β-D-阿拉伯呋喃糖基胞嘧啶(阿糖胞苷,ara-C)的代谢参数,以了解在体外使用9种人淋巴细胞系、3种T细胞系和6种B细胞系是否能够预测阿糖胞苷敏感性。1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸(ara-CTP)的合成、降解能力(通常T细胞系低于B细胞系)以及阿糖胞苷的脱氨基作用(在B细胞系中可忽略不计)均与药物敏感性无关。另一方面,敏感性与ara-CTP的平台水平之间存在显著相关性。我们认为,在化疗开始前通过测量ara-CTP的平台水平可以预测阿糖胞苷敏感性。